Home

CME Live Seminars
CME Video DVD
CME Audio CD/MP3
   Course Titles
   About the Program
   Quick Order
   Certificate Packages
   Accreditation
   Money Back Guarantee
   Tax Deductibility
   Testimonials

Subscribe
Request Brochure
Hold Seat
Testing Online
Faculty
Resources
Contact Us

Specific Learning Objectives
Additional Certificate Packages
Refer a Colleague to Our Website
What do our past participants have to say?

by William T. Ayoub, M.D., F.A.C.P., F.A.C.R. - Geisinger Medical Group, Geisinger Health System; Associate, Department of Rheumatology; State College, PA; Lawrence H. Brent, M.D. - Jefferson Medical College, Thomas Jefferson University; Associate Professor of Medicine; Head, Division of Rheumatology and Director, Einstein Arthritis Center, Albert Einstein Medical Center, Philadelphia, PA; Glenn Eiger, M.D., F.C.C.P., F.A.C.P. - Jefferson Medical College, Thomas Jefferson University; Associate Professor of Medicine; Director, Internal Medicine Residency Program and Associate Chairman, Department of Medicine, Albert Einstein Medical Center, Philadelphia, PA; Keith S. Kaye, M.D., M.P.H. - Wayne State University School of Medicine; Professor of Medicine, Division of Infectious Diseases; Corporate Medical Director of Hospital Epidemiology and Antimicrobial Stewardship, Detroit Medical Center, Detroit, MI; Kim Edward LeBlanc, M.D., Ph.D., F.A.A.F.P., F.A.C.S.M. - Louisiana State University Health Sciences Center School of Medicine; Marie Lahasky Professor and Head, Department of Family Medicine; Professor, Department of Orthopedics and Director, Rural Education; Certificate of Added Qualifications in Sports Medicine, New Orleans, LA; Jeffrey Miller, M.D. - Penn State College of Medicine; Associate Professor of Dermatology, Vice-Chair, Department of Dermatology; Hershey, PA; Herbert L. Muncie, Jr., M.D. - Louisiana State University Health Sciences Center School of Medicine; Professor of Family Medicine and Director, Medical Student Education, Department of Family Medicine; New Orleans, LA; Albert J. Peters, D.O., F.A.C.O.G. - Sher Institute for Reproductive Medicine (SIRM); Medical Director; New Jersey; Gary H. Oberlender, M.D., F.A.C.P. - Consultant in Geriatric Medicine; Gerald W. Smetana, M.D. - Harvard Medical School; Associate Professor of Medicine; Senior Physician, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA; C. Christopher Smith, M.D. - Harvard Medical School; Associate Professor of Medicine; Associate Director, Internal Medicine Residency Training Program, Associate Firm Chief, Blumgart Medical Firm, and Co-Director, Rabkin Fellowship in Medical Education, Beth Israel Deaconess Medical Center of Harvard Medical School, Boston, MA; Frederick Sunderlin, M.D. - Jefferson Medical College, Thomas Jefferson University; Clinical Professor of Medicine; Associate, Department of Endocrinology, Geisinger Medical Center; Adjunct Professor of Medicine, Temple University School of Medicine; Clinical Professor, School of Graduate Studies, Lock Haven University, Lock Haven, PA and Gregory Tino, M.D., F.C.C.P., F.A.C.P. - University of Pennsylvania School of Medicine; Associate Professor of Medicine; Chief, Pulmonary Clinical Service, Hospital of the University of Pennsylvania, Philadelphia, PA.

PURPOSE: The purpose of the American Medical Seminars, Inc. CME Program is to develop and deliver clinically relevant, evidence-based CME activities in an effort to align physician behavior with current clinical guidelines and the evidence to improve their competence and the care they provide their patients.

OVERALL OBJECTIVES: Upon completion of this CME activity, through the use of clinical vignettes emphasizing Guidelines and Evidence-Based Medicine, the physician or healthcare provider should be able to formulate a differential, make a diagnosis and develop a plan for the prevention and/or therapeutic management of the various disorders presented.

SPECIFIC OBJECTIVES FOR EACH TOPIC
TOPIC 1	Sensible Prescribing Practices for the Elderly - Upon completion of this session, the participant should be able to: 1. Recognize the limits of studies on drug safety and efficacy as they apply to the elderly. 2. Appreciate the subtle but significant drug side effects in the elderly. 3. Describe undesirable prescribing practices and better approaches.
TOPIC 2	Newer Antibacterial Agents - Upon completion of this session, using FDA publications and approvals as well as IDSA and SHEA evidence-based guidelines, the participant should be able to: 1. Relate the antibacterial spectrum of activity. 2. Describe the pharmacology of the agents. 3. List the indications and dosing recommendations. 4. Identify the side effects, adverse reactions and drug interactions.
TOPIC 3	Adult Health Screening and Immunizations – Evidence-Based Approach - Upon completion of this session, using the USPSTF and Cochrane Abstract Database, the participant should be able to: 1. Describe the evidence-based recommendations for preventive screening tests for adults. 2. List the routine immunizations recommended for adults. 3. Describe the common side effects of adult immunizations. 4. List the contraindications for each adult immunization. 5. Discuss when screening tests can be discontinued in adults.
TOPIC 4	Treatment of Primary Headache Syndromes - Upon completion of this session, the participant should be able to: 1. Appreciate the role of abortive therapy for migraine, tension-type, and cluster headache. 2. Recognize the range of options for pharmacologic preventive therapy for migraine, tension-type, and cluster headache. 3. Develop non-pharmacologic treatment strategies for migraine.
TOPIC 5	Evaluation of Abnormal Liver Enzymes in the Primary Care Setting - Upon completion of this session, the participant should be able to: 1. Describe a diagnostic approach to assess patients with asymptomatic elevations in liver studies. 2. Describe the common causes of asymptomatic elevations in transaminase levels. 3. Review the natural history of hepatitis B infection, including serologic markers and indications for treatment. 4. Review the epidemiology, evaluation and potential treatment options for nonalcoholic steatohepatitis.
TOPIC 6	Thyroid Case Studies - Upon completion of this session, the participant should be able to: 1. Review the etiologies and pathogenesis of hyper and hypothyroidism. 2. Apply cost effective principles in the laboratory evaluation of thyroid conditions. 3. Design effective treatment protocols for various thyroid conditions.
TOPIC 7	Lung Cancer - Primary lung cancer remains a major cause of morbidity and mortality. A number of new approaches to diagnosis and therapy have been developed. Upon completion of this session, the participant should be able to: 1. Discuss the epidemiology of lung cancer. 2. Define the major types of lung carcinoma, particularly small cell and non-small cell cancer. 3. Characterize the basic clinical aspects of both small cell and non-small cell cancer including staging, natural history, and associated extrapulmonary syndromes. 4. Outline a diagnostic strategy for patients with suspected lung cancer. 5. Identify current treatment options for small cell and non-small cell lung cancer.
TOPIC 8	Interstitial Lung Disease - The focus of the discussion will be on sarcoidosis and idiopathic pulmonary fibrosis. These are two disorders a primary care provider should be familiar with. We will review the recent literature so that upon completion of this session, the participant should be able to: 1. Characterize the spectrum of interstitial lung disease. 2. Develop a basic understanding of the diagnostic work-up, which can include high resolution CT scanning and tissue biopsy. 3. Identify the clinical and radiographic manifestations of sarcoidosis. An overview of management will be provided. 4. Outline the typical presentation of idiopathic pulmonary fibrosis as well as management issues. We will present a variety of cases with x-rays, CT scans and pathology to illustrate important features. The discussion will focus on basic concepts and will include guidelines on specialist’s referral.
TOPIC 9	Integrative Medicine: Common Therapies - Upon completion of this session, using systematic reviews of clinical evidence, the participant should be able to: 1. Identify the ten most commonly used natural products. 2. Discuss the science of the use of these natural products. 3. Review the indications and contraindications for the use of these natural products and potential drug interactions.
TOPIC 10	Chronic Anovulation - Upon completion of this session, the participant should be able to: 1. Discriminate between the hypothalamic, pituitary and ovarian causes of anovulation. 2. Investigate associated health risks. 3. Formulate an appropriate treatment regimen.
TOPIC 11	Evaluation and Initial Management: Benign Breast Disease - Upon completion of this session, using the American Cancer Society guidelines as well as the Cochrane Abstract Database, the participant should be able to: 1. Describe benign breast disease. 2. Evaluate for various conditions such as breast pain, breast lumps, and nipple discharge. 3. Describe findings associated with breast cancer.
TOPIC 12	Rheumatology Pearls - Upon completion of this session, the participant should be able to: 1. Outline several clinical points related to rheumatic diseases which emphasize efficient diagnosis and treatment.
TOPIC 13	Spondyloarthropathies - Upon completion of this session, the participant should be able to: 1. Differentiate the clinical features of the different spondyloarthropathies to improve diagnostic accuracy. 2. Describe treatment modalities.
TOPIC 14	Abnormal Uterine Bleeding - Upon completion of this session, the participant should be able to: 1. Define abnormal uterine bleeding. 2. Differentiate between functional and organic causes. 3. Manage most non-surgical etiologies of this problem.
TOPIC 15	Anemia: A Finding, Not Yet a Diagnosis - Upon completion of this session, using the Cochrane Abstract Database, the participant should be able to: 1. List the most common anemias and their usual etiology. 2. Compare the diagnostic evaluation needed to determine the etiology of the anemia. 3. Identify the therapeutic options for each of the identified anemias. 4. Describe the follow-up plans for assessing the efficacy of treatment for each anemia.
TOPIC 16	The Most Common Dermatology Referrals - Upon completion of this session, the participant should be able to: 1. Identify the most common dermatology referrals 2. Develop referral strategies for the common dermatology referrals. 3. Initiate treatment regimens for the common dermatology referrals.

Home

Course Titles & Tuition

Quick Order

E-Mail